Log In
Print
BCIQ
Print
Print this Print this
 

Sym004

  Manage Alerts
Collapse Summary General Information
Company Symphogen A/S
DescriptionCombination of 2 anti-EGFR mAbs against 2 distinct and non-overlapping epitopes in the extracellular domain III of EGFR
Molecular Target Epidermal growth factor receptor (EGFR)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today